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The purpose of these studies has been to 
attempt to clarify the mode of action of dithiols 
when administered to animals poisoned with gold, 
mercury, or lead. For an understanding of the 
problems involved, it is necessary to review briefly, 
the evidence which. led to the introduction of di- 
thiols as antidotes to poisoning by first, arsenic, 
and secondly, various other metals. 
After the identification of thiol groups in 
living cells, Ehrlich suggested, in 1909, that 
arsenic combined with the thiol groups of tissue 
constituents, and exerted its toxic effects as a 
result of this combination. Direct evidence in 
favour of this view was provided by Walker (1924, 
'quoted by Stocken and Thompson, 1946a), who investi- 
gated the action of arsenicals on dried muscle 
powder. He found that the arsenicals caused a pro- 
gressive inhibition of certain catalytic effects 
shown/ 
2. 
shown by this preparation, and that it was accompan- 
ied by a disappearance of protein thiol groups. 
Rosenthal (1932) established that trivalent arseni- 
cals did combine with the thiol groups of tissue 
proteins. 
Many important enzymes depend on free thiol 
groups for their activity (Hellermann, 1937; Barron 
and Singer, 1943; Peters et al., 1946). One enzyme 
in particular, pyruvate oxidase, was found to be 
markedly inhibited by arsenic (Peters, 1936; 1937). 
Peters suggested that this enzyme contained essential 
thiol groups; and this was supported by the fact 
that iodoacetate, which was known to combine with 
thiol groups (Dickens, 1933), is also a potent inhib- 
itor of pyruvate oxidase. Eventually, the existence 
of essential thiol groups in this enzyme was demon- 
strated (Barron and Singer, 1945; Peters and Wakelin, 
1946). Present knowledge of the central position 
of this enzyme in cell metabolism makes it obvious 
that any inhibition would cause widespread effects. 
Meanwhile, Voegtlin and his associates had 
found that simple monothiols, such as cysteine and 
reduced glutathione, could diminish the trypanocidal 
and/ 
3. 
and toxic effects of oxophenarsine or sodium arsen- 
ite (Voegtlin et al., 1923, 1925; Rosenthal and 
Voegtlin, 1930). It was also shown that the re- 
duction in oxygen consumption of animal tissues 
caused by oxophenarsine or sodium arsenite, could be 
prevented by the addition of glutathione (Voegtlin 
et al. 1931). In all these experiments, however, 
a large excess of the monothiol was required in order 
to antagonize the action of the poison. Glutathione 
is also capable of abolishing the anti - spirochaetal 
action of oxophenarsine, but again a large excess 
of glutathione is required (Eagle, 1939). 
Schmitt and Skow (1935), investigating the 
action of arsenite on nerves, found that glutathione 
and cysteine could delay the extinction of the nerve 
action potential by arsenite; but even high concen- 
trations of monothiols could not prevent the eventual 
extinction, nor could they reverse it once it was 
established. 
Lewisite was found to be a more potent inhibi- 
tor of pyruvate oxidase than were any of the thera- 
peutic arsenicals, and monothiols were unable to 
afford/ 
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afford any protection against this substance (Peters 
et al. 1946; Stocken and Thompson, 1946b). 
Cohen, King and Strangeways (1931), studying 
the reactions between aromatic arsenicals and thiols, 
found that the equilibrium - 
i 
EAsO + 2R SH RAs(SR )2 + H2O 
is shifted to the left as the pH increases. Excess 
of thiol favours the opposite reaction. However, 
Strangeways (1937) showed that, in dilute solutions, 
hydrolysis of thioarsinites predominates, and the 
protection afforded by glutathione against oxophen- 
arsine becomes less complete with progressive dilu- 
tion. 
Thus it was evident that monothiols could afford 
some degree of protection against oxophenarsine, but 
not against the more toxic arsenicals. It seemed 
probable that this variation in activity was due to 
differences in the degrees of dissociation of the 
respective thioarsinites. 
The advent of the war in 1939 initiated an 
investigation, under the direction of Peters, into 
the actions of arsenical war -gases. The reactions 
of arsenicals with proteins were investigated, using 
the/ 
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the thiol- containing protein, kerateine. Analyses 
of the arsenical- kerateine complexes showed that the 
arsenic had combined solely with thiol groups, and 
that most of the arsenic appeared to be in combin- 
ation with two adjacent thiol groups, forming a ring 
structure ( Stocken and Thompson, 1946a). This evi- 
dence suggested that, in order to remove arsenic 
from protein, a dithiol, capable of forming an even 
more stable cyclic thioarsinite, would be required. 
1 : 2,- or 1 : 3,- substituted dithiols were the 
obvious choice, since these would form five- or 
six -membered rings:- 
-c----s. 
\As- or \C/ \As- 
-C si C / \ 
It may be noted that support for this concept was 
given later by Whittaker (1947), who synthesized a 
series of dithiols, and found that those forming 
such rings had the highest antidotal activity. 
Several dithiol compounds were prepared and 
tested for their ability to protect the pyruvate 
oxidase/ 
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system against inhibition by lewisite and to cause 
survival of animals contaminated with lewisite. 
The dithiols were generally quite successful in 
these tests, but one, 2,3- dimercaptopropanol, was 
considered more suitable for therapeutic purposes 
because of its physical properties and lower tox- 
icity. It was therefore subjected to further test- 
ing as an antidote to lewisite or arsenite poisoning 
in animals, and then for its ability to prevent 
vesication by lewisite in man. The results of all 
these experiments indicated a high antidotal activ- 
ity (.tocken and Thompson, 1946b). This conclusion 
was completely confirmed in later studies, both in 
experimental (stocken et al. 1947; Eagle et al. 
1946; Riker, 1946; Harrison et al. 1946a and b; 
etc.) and in clinical cases of arsenical poisoning 
(Longcope et al. 1946; Carleton et al. 1946; Eagle 
and Magnuson, 1946; Carleton et al. 1948; etc.). 
2,3- dimercaptopropanol was named British Anti - 
Lewisite (B.A.L.) during the war, but since then has 
been termed dimercaprol. It is a fairly toxic 
substance, and this has prompted investigation of 
related compounds for their anti -arsenical activity 
and/ 
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and toxicity. Besides those substances tested by 
Stocken and Thompson (1946b), a number of other 
dithiols have been studied (Chenoweth et al. 1946; 
Fitzhugh et al. 1946; Weatherall, 1949). So far, 
only one substance, the glucoside of dimercaprol 
(BAL- Intrav), has been shown to possess any advan- 
tages over dimercaprol itself (Danielli et al. 1947). 
This substance is much less toxic than dimercaprol 
and possesses considerable anti- arsenical activity, 
though it does not appear to be as effective as 
dimercaprol when administered after poisoning with 
arsenic has been established ( Weatherall, 1949). 
When the effectiveness of dimercaprol in arsenical 
poisoning had been demonstrated, investigations were 
extended to poisoning by other metals. Many heavy 
metals readily form mercaptides, and a number re- 
act with dimercaprol, giving almost insoluble, 
coloured compounds (Barron et al. 1947). 
In the case of mercury, previous observations 
tended to support the view that compounds of this 
metal reacted with essential thiol groups in enzymes 
(Hellermann, 1937). Eagle (1939) obtained reversal 
of the spirochaeticidal action of mercury by gluta- 
thione;/ 
8. 
glutathione; and the latter substance prevented the 
inhibition of growth of Esch coli by mercuric 
chloride ( Filles, 1940). Glutathione can also 
reverse the inhibition of the pyruvate oxidase 
system of gonococci caused by p-chloromercuri- 
benzoic acid (Barron and Singer, 1945). 
Thompson and Whittaker (1947) found that both 
dimercaprol and glutathione could protect the pyruv- 
ate oxidase system of brain from inhibition by 
mercuric chloride, but Barron and Kalnitsky (1947), 
using the enzyme succinoxidase, reported that dimer- 
caprol was definitely superior to glutathione. 
The results of a large number of animal experi- 
ments have shown that dimercaprol can counteract 
the toxic effects of mercuric chloride (Braun et al. 
1946; Gilman et al. 1946a; Ginzler, 1946; Stocken, 
1947; Graham and Hood, 1948), and of organic mer- 
curials (Long and Farah, 1946; Handley and La Forge, 
1947; Susemann and Schack, 1947) . It has also 
been found that dimercaprol glucoside is more 
effective than dimercaprol in preventing the toxic 
effects of mercuric chloride, by Harrison and 
Randoll (1948), using a tissue- culture technique; 
and,/ 
9. 
and by Gilman et al. (1946a), studying the acute 
poisoning of rabbits and dogs. 
Clinical reports have confirmed the effective- 
ness of dimercaprol therapy in acute mercuric 
chloride poisoning (Longcope and Luetscher, 1946 
and 1949). 
Gold salts inhibit the pyruvate oxidase system, 
and this action can be prevented by dimercaprol 
(Thompson and Whittaker, 1947). Dimercaprol 
decreases the toxicity of.gold sodium thiosulphate 
in mice (Swanson et al. 1947), and can increase 
the survival -time and growth -rate of rats poisoned 
with certain gold salts, but the dimercaprol -gold 
complex appears to have an injurious effect on the 
kidney (Levey and Smyth, 1947). However, Kuzell 
et al. (1948) reported that dimercaprol could prot- 
ect rats against a lethal dose of gold sodium thio- 
sulphate injected intramuscularly, but not against 
a lethal dose of gold chloride given by the intra- 
peritoneal route. Clinical reports have indicated 
a favourable response to dimercaprol therapy in 
cases of toxic reactions to gold (Cohen et al. 1947; 
Lockie et al. 1947; Margolis and Caplan, 1947; 
Ragan/ 
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Ragan and Boots, 1947; etc.). 
The treatment of experimental lead poisoning 
by dimercaprol has produced much conflicting evidence. 
Braun et al. (1946) found that dimercaprol increases 
the mortality rate of rabbits injected intraperi- 
toneally with lead nitrate, but decreases the 
mortality after intravenous injection of lead acet- 
ate (Braun et al. 1949). On the other hand, 
Germuth and Eagle (1948) reported that dimercaprol 
failed to protect rabbits after intravenous or sub- 
cutaneous injection of lead acetate, though the 
excretion of lead was increased. The latter finding 
was also reported by Ginsburg and Weatherall (1948) . 
Weatherall (1948) showed that dimercaprol had little 
effect on the mortality of mice receiving repeated 
intraperitoneal injections of lead acetate, but di- 
mercaprol glucoside caused a significant reduction 
in mortality. He also found that the anaemia of 
acutely lead- poisoned rabbits could be diminished 
by both dithiols. The nephrotoxic action of lead 
in rats can be prevented by dimercaprol (Chiodi and 
Martino, 1948). However, dimercaprol has little 
effect in increasing the excretion of lead in more 
chronic/ 
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chronic phases of poisoning in rabbits (Adam et al. 
1949) or mice (Anderson, 1949). 
In clinical cases of lead poisoning, dimercap- 
rol therapy has been found to increase the urinary 
excretion of lead, but conflicting opinions have 
been given of its possible therapeutic value (Ryder 
et al. 1947; Telfer, 1947; Longcope and Luetscher, 
1949). 
Dimercaprol has also been reported to reduce 
the mortality of animals poisoned with cadmium 
(Gilman et al. 1946b; Tobias et al. 1946; Harrison 
et al. 1947), antimony (Braun et al. 1946; Eagle et 
al. 1947), bismuth, chromium and nickel (Braun et al. 
1946), tungsten and copper (Braun et al. 1949). 
Dimercaprol is stated to be ineffective in poisoning 
by iron (Edge and Somers, 1948), silver (Olcott and 
Riker, 1947), thallium and selenium (Braun et al. 
1946), vanadium (Braun et al. 1949) and uranium 
(Macnider, 1948; Braun et al. 1949). These con- 
clusions are by no means unanimous. For instance, 
Gammill et al. (1947) found that dimercaprol inc- 
reased the toxicity of various antimonials; Graham 
and Hood (1948) reported that dimercaprol had a 
deleterious/ 
12. 
deleterious effect in poisoning by bismuth. It 
seems likely that these findings are largely con- 
ditioned by the methods of poisoning and treatment. 
The following studies of the effects of dimer- 
caprol or dimercaprol glucoside on the distributions 
of mercury, gold and lead, were undertaken in an 
attempt to clarify their antidotal actions. Similar 
work has been carried out by Tepperman (1947) in 
the case of cadmium, by Ginsburg and Weatherall (1948) 
in the case of lead, and by Bruner (1950) for zinc. 
These experiments also provided an opportunity 
for a fresh examination of the distributions of 
mercury and gold. 
13. 
METHODS 
Materials : - The dimercaprol was a water -purified 
sample, and was stored in a refrigerator when not in 
use. Solutions in 66¡ (v /v; aqueous propylene gly- 
col were made up freshly as required. 
Dimercaprol glucoside was received as the bar- 
ium salt, contained in nitrogen -filled ampoules. 
Solutions of the free dithiol were obtained by add- 
ing sulphuric acid to an aqueous suspension of the 
barium salt, and centrifuging off the barium sulph- 
ate. Complete removal of the barium was ascertained 
by observing the absence of a precipitate after the 
addition of saturated sodium sulphate solution, and 
the solution of the dithiol was neutralized with 
sodium hydroxide. All dimercaprol glucoside solu- 
tions were made up freshly immediately before use. 
The impurity of the preparations of dimercaprol 
glucoside necessitated estimations of the thiol con- 
tent of each solution, by means of iodine titration. 
N /10 iodine was titrated against the dithiol in the 
presence/ 
14. 
presence of N. hydrochloric acid, and at a tempera- 
ture of 0 °C. A less sharp end -point is obtained 
if the titration is carried out at room -temperature. 
All doses of the glucoside were calculated from the 
estimated thiol contents. This procedure gave 
slightly variable results, but is probably more 
satisfactory than calculating the dosage from the 
weight of barium salt used (weatherall, 1949). 
1:3- dimercaptopropanol was synthesized by 
Dr. L.A. Stocken, and 1 :4- dithioerythritol by Dr. L. 
N. Owen. Both substances were of 95 -100% purity, 
and were dissolved in water for administration. 
The parathyroid extract used in the sub -acute 
distributions of lead was a commercial preparation 
( "Parathormone" Lilly). 
The radio -active isotopes of gold and mercury 
198 203-205 
(Au and Hg ) were obtained by neutron 
irradiation of the respective chlorides at the 
Atomic Energy Research Establishment, Harwell. The 
irradiation caused the formation of radio- active 
3s 
chloride (C1 ) as well, and it was necessary to 
remove the latter in order to prevent interference 
with the estimation of radio -activity due to the 
metal/ 
15. 
metal alone. This removal was carried out by 
dissolving the salt in water, and reducing it to 
the metal with stannous chloride in the case of 
mercury, and with ferrous sulphate in the case of 
gold. The metal was centrifuged off, and the 
supernatent liquid discarded. After washing with 
water, the metal was dissolved in aqua regia, and 
gently heated almost to dryness. Drying was com- 
pleted in a vacuum desiccator. 
In the case of gold, solutions for injection 
were prepared by adding a trace of the isotope to 
solutions of gold chloride. The poor specific act- 
ivity of the mercury necessitated its quantitative 
transfer to injection solutions. 
One radio -active isotope of lead (Thorium B, 
212 
Pb ) was obtained from the deposit on a charged 
button exposed to a thorium source. The button was 
heated gently in a slightly acidified 0.01 (w /v) 
solution of lead acetate, so that the Pba 
Q 
exchanged for part of the lead in solution. Further 
lead acetate was then added according to the desired 
210 
dosage. The other isotope (radium D, Pb ) was 
obtained from an equilibrium mixture of radium D, E, 
and/ 
16. 
and F, by displacing the radium E and F with nickel, 
added as foil to a solution in hydrochloric acid. 
A small quantity of the resulting solution of radi- 
um D was added to a solution containing lead acet- 
ate, so that the final solution contained 2.O7mg. 
f lead and 2 -3 microcuries of radium D per m7_. 
The concentrations of gold, mercury, or lead 
solutions were adjusted so that a volume of 1.0m1. 
was injected per kg. of body weight. The solutions 
were rendered isotonic with dextrose, and were 
neutralised before injection. Solutions of mercuric 
chloride tended to be rather acid, however, as the 
further addition of alkali caused the formation of 
insoluble basic chlorides. 
The relevant physical properties of these iso- 

































































































































































































































































ANIKALS:- Adult rabbits, of both sexes and 
various breeds, were used throughout these experi- 
ments. Injections of gold, mercury, or lead solu- 
tions were made into the marginal vein of one ear, 
each injection lasting 2 -3 minutes. The animals 
were then placed in metabolism cages. Water was 
allowed ad libitum. For experimental periods last- 
ing longer than 24- hours, food was also provided, 
and consisted of bran and oats, with cabbage every 
two or three days. Vessels containing food or 
water were placed outside the cage, so that no con- 
tamination of the urine or faeces could occur. 
Injections of dithiols were made into the 
paravertebral muscles. The doses of dithiols were 
near the toxic range since maximal effects were 
being sought. The doses usually employed were 
50mg. /kg. and 12.5mg. /kg. of dimercaprol, and 
175mg. /kg. and 55mg. /kg. of dimercaprol glucoside. 
Expressed in terms of molar weights, these doses 
correspond approximately to 0.4rM. /kg. and 0.1mM /kg. 
of dimercaprol, and 0.6mM . /kg. and 0.2nM . /kg . of the 
glucoside. Thus, a larger number of molecules of 
dimercaprol/ 
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dimercaprol glucoside than of dimercaprol was 
administered. Injections of saline or propylene 
glycol were given to the control animals. At the 
end of the desired distribution period, the animals 
were killed by a blow on the occiput. 
SAMPLING OF TISSUES:- Immediately after death, 
blood was collected by bleeding from the great veins 
into the thorax. Clotting was prevented by heparin, 
and the samples were centrifuged at once. Usually 
about 10m1. of blood was taken. 
The organs were then dissected out taking care 
to avoid contamination between different tissues. 
Complete organs were washed with water, dried bet- 
ween filter- papers, and weighed. If the organ 
weighed less than 10g. it was ashed entire. In 
other cases, samples were taken from well -mixed 
choppings of the organ. Skeletal muscle samples 
were taken from the thigh, and bone samples from 
the long bones of one fore limb and one hind limb. 
Marrow was removed from diaphyses and estimated 
separately, and was washed, as far as possible, 
from samples of. epiphyses. The injected ear, and 
the/ 
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the piece of cotton wool used to control bleeding, 
formed a separate sample, so that the quantity of 
metal remaining at the site of the injection was 
known. The opposite ear was taken as a sample of 
skin. 
Duplicate samples of liver and kidney were taken 
routinely, and provided an estimate of the error of 
the determinations. 
ASHING OF SAMPLES:- After weighing, the tissues 
were placed in Kjeldahl flasks, containing 30m1. 
conc. nitric acid and 20m1. of 20 (v/v) perchloric 
acid, and were allowed to stand for several hours. 
1The flasks were heated gently until the contents 
were boiling, taking care to avoid excessive foaming, 
and were then allowed to boil very gently until 
about 10m1. of solution remained. If this solution 
was not quite clear, a further 20m1. of nitric acid 
was added and boiling continued. Generally, it 
proved impossible to obtain a clear solution of 
faeces. 
The solutions were then transferred to boiling - 
tubes, and diluted with water to a known volume, 
usually 50m1. Urine and bile were not subjected 
to/ 
21. 
to ashing, but were estimated directly. In the 
case of the sub -acute distributions of lead, samples 
were allowed to stand for at least five weeks to 
allow an equilibrium mixture of radium D and E to 
form, because the counter used was not sufficiently 
sensitive to detect the low- energy 1 -rays, emitted 
by the radium D, but counted the more energetic 
emission from radium E. 
ESTIMATION OF RADIO- ACTIVITY: - The activity of 
the samples was measured by means of an M.R.C. 
Type 1 fluid Geiger -Muller counter. Preliminary 
experiments showed that the total count per minute, 
corrected for the background count, was linearly 
related to the amount of radio -active material 
present, in the case of each isotope. 
Variations in the density of the solutions, 
within the range involved in the experiments, 
affected the counts of Pb 21 and Pb 
210 
negligibly. 
203 -208 188 
The radiations of Hg and Au were absorbed 
to a greater extent, however, and graphs were drawn 
relating the decrease in count to the density of 
the solution. The density of each sample was 
measured 
22. 
measured by simple hydrometers, and the count of 
the sample corrected by reference to the appropriate 
graph. 
From the counts obtained from aliquots of the 
injection solution, and the counts obtained from 
samples of tissues under similar conditions, the 
proportion of the dose in each sample, and hence 
the concentration of metal in the tissue, was 
calculated. 
Although counts from such aliquots were made 
several times during each experiment, the shortness 
212 19e 
of the half -lives of Pb and Au necessitated 
a correction for the decay occurring during the 
counting of the samples of any one experiment. 
Each count was corrected by means of the formula, 
No = Nt e at 
where No = the number of atoms of isotope present 
initially 
Nt = the number of atoms of isotope present 
after a time t 
212 
and a = disintegration constant, which for Pb 
r3 1 19e 






The half -lives of HE and radium D were con- 
sidered sufficiently long to neglect the effect of 
decay. 
The proportion of the dose in any organ was 
calculated from the known weight of the organ, and, 
for the purpose of estimating the total recovery, 
the following approximate values for various tissues 
were used:- total blood volume - 70m1./kg.; 
total weight of bone marrow - 20g. /kg. (Nye,1931); 
total weight of bone - 60g. /kg.; 
total weight of skin -120g. /kg.; and 
total *eight of skeletal muscle -520g. /kg. (Levine 
et al. 1941). The amounts in bone were calculated 
from the mean value for both diaphyses and epi- 
physes. This is not an accurate estimate and is 
useful only as a rough check that a reasonable 
fraction of the dose has been accounted for. 
The standard error, obtained from the duplicate 
samples of liver and kidney, of the mercury esti- 
mations was 14 %; of the acute lead estimations 
4%; of the sub -acute lead estimations 
t 
12%; and 
of the gold estimations 8%. 
24. 
RESULTS 
Part 1: Mercury. 
Results are presented for the distribution 
and excretion of mercury in twenty-eight rabbits, all 
of which received a single intravenous dose of mercu- 
ric chloride, either 5µM. /kg. or 3.7vM /kg. and were 
killed after various periods of time. Some animals 
were treated with dimercaprol, and some with dimer- 
caprol glucoside, at different times after the inject- 
ion of mercuric chloride. The larger dose of mer- 
cury usually, and the lower dose occasionally, 
caused some degree of damage to the kidneys, as 
demonstrated by the presence of albumen and casts in 
the urine. As far as could be judged, this damage 
was less marked in treated animals. No other signs 
of toxic effects were noted, apart from general 
apathy, in the poisoned animals. 
It should be noted that recoveries ranged from 
70 -90 %. Preliminary recovery experiments showed 
that/ 
25. 
that as much. as 50% of the mercury could be lost 
during ashing if the acid solutions were boiled 
vigorously. Allowing the solutions to evaporate 
under gentle heating reduced the loss to about 20 %. 
As urine and bile were not ashed, mercury was not 
lost from these fluids in this way. 
A further point of note is that variable quanti- 
ties of mercury were left at the injection site, and 
in a few cases this amounted to as much as one -third 
of the dose. In these cases, the injections had 
been difficult due to blocking of the vein into which 
the injection was given, and this was probably the 
result of the acidity of the injection solutions. 
The mercury itself tends to irritate veins on intra- 
venous injection, and may have contributed to the 
blockage. 
Lastly, the error of the estimations was 
approximately ± 14%. This is higher than in the 
cases of lead and gold, and the increase is mainly 
if not entirely. due to the lower specific activity 
of the mercury. The time of counting samples was 
not increased sufficiently to attain the same accu- 
racy as was obtained with the more active isotopes. 
These 
26. 
These three factors should be kept in mind when com- 
paring results obtained in different animals. 
In Tables 2 and 3, results are presented for 
rabbits which received 5µI. /kg. (1.0mg. Hg. /kg.) of 
mercuric chloride intravenously, and no further 
treatment. The concentrations of mercury in micro - 
grammes per gramme of tissue are shown in Table 2, 
and the percentages of the dose found in various 
organs and calculated for various tissues are shown 
in Table 3. 
Although considerable variation occurred between 
rabbits receiving the same treatment, certain general 
trends can be seen. One hour after the injection of 
mercury, a small quantity of the element remained in 
the plasma; but within six hours, the amounts had 
fallen and were generally below the detectable level. 
Of all the organs and tissues sampled, the kidneys 
contained. by far the highest concentration of mercury, 
and, after twenty -four hours, accounted for 20 -30% 
of the mercury absorbed. The liver generally 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































concentration did not alter significantly during 
fourteen days after the injection of mercury. The 
next highest concentration usually occurred in the 
lungs, while heart, spleen and brain contained only 
very small quantites. A high concentration of 
mercury was found in bone marrow after one hour, but 
this fell below the detectable level later; similar- 
ly, the concentrations in bone decreased, and only 
very small amounts of mercury were found in this site 
after twenty -four hours. Skin usually held a few 
per cent of the dose, but skeletal muscle contained 
only small quantities. The amount of mercury in the 
gastro -intestinal tract rose during the first few 
hours, as excretion increased, then maintained a 
fairly steady concentration for a few days. Very 
small amounts occurred in the stomach, but the stom- 
ach contents usually showed a much higher concen- 
tration of mercury, perhaps because of the excretion 
of the metal in the saliva. After twenty -four hours, 
the small intestine, caecum, and colon contained 
small and similar concentrations, but again higher 
concentrations of mercury were generally found in the 
respective contents. A high concentration was found 
in/ 
30. 
in the bile after one hour, but thereafter the 
quantities of mercury in this fluid were below the 
level of detection. 
About 4% of the dose was excreted in the urine 
within an hour, but this rate slowed considerably, 
and after twenty -four hours the urine contained 
6 -15% of the dose or 9-19% of the mercury absorbed. 
Only about two -fifths of the dose was excreted in 
the urine in fourteen days. About 1% of the dose 
was found in the faeces after twenty -four hours, 
but this rate of excretion increased, and nearly 27% 
was excreted in this way in fourteen days. Details 
of the excretion of mercury during the five -day and 
fourteen -day experiments are given in Tables 4 and 
5. 
The effect of administration of dimercaprol is 
shown in Tables 6 and 7. The doses of dimercaprol, 
and the times after the injection of mercury at 
which they were given, are set out in these tables. 
Generally, little change occurred in the qualitative 
aspect of the distributions, but considerable 
quantitative differences were found. The concen- 





The concentrations of mercury found in samples of urine after 
the intravenous injection of 5 p1. /kg. of mercuric chloride. Each 
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1t! +11 1í1i 
The concentrations of mercury found in samples of urine after 
the intravenous injection of 5)UK. /kg. of mercuric chloride. Each 
arrow represents the injection of propylene glycol or of 12.5 mg. /kg of dimercaprol. 
_tT .. y,_.. :..: 
::: :::::: 
7__._.7_: 
RABBIT 359 (CON TROL) 
RABBIT 360 (TREATED WITH DIMERCAPRO 
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decrease, and this effect was most marked in those 
tissues containing the highest concentrations in 
untreated animals. The amounts of mercury in the 
kidneys fell profoundly. The concentration of mercur 
in the liver were generally, but not significantly, 
smaller than those of the untreated animals. The 
quantities of mercury in the gastro- intestinal tract 
tended to decrease, but no definite effect on the 
excretion of mercury in the faeces was observed. 
analler amounts of mercury were usually found in skin, 
but the decrease was not significant. The loss of 
mercury from these tissues was paralleled, and account- 
ed for, by a greatly increased excretion of mercury in 
the urine, and possibly by an increase in the amounts 
in skeletal muscle in some cases. 
These actions of dimercaprol were found, though 
on a smaller scale, even when treatment was delayed 
until nine days after the administration of mercury. 
The two rabbits killed after five days showed similar 
amounts of mercury in the urine, but it should be 
noted that the rabbit (No.364), treated with dimer- 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The amounts of mercury excreted in both urine 
and faeces during the five and fourteen days experi- 
ments are shown in Tables 4 and 5. When dimer- 
caprol was administered three days after the mercury, 
an increase occurred in the concentration of mercury 
in the urine, as shown in Fig.'. Treatment begun 
nine days after the mercury had a simi].ar effect, 
but this disappeared rapidly, in spite of continued 
treatment, (Fig.2). 
The results of treatment with dimercaprol glu- 
coside are presented in Tables 8 and 9. Consider- 
able differences from the actions of dimercaprol were 
found. The mercury content of the plasma was con- 
sistently raised, and in the cases of rabbits No.400 
and 402, the content of the erythrocytes was also 
increased. Large increases in the concentration of 
mercury in the bile occurred, but the amounts of 
mercury contained in the small intestine, colon, 
and their contents, were generally similar to those 
found in untreated animals. No definite change in 
the concentration of mercury in the liver was ob- 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































diminished to an extent similar to that occurring 
in dimercaprol- treated animals. The quantities 
of mercury in skin tended to increase, but the 
difference was not significant. 
The urinary excretion of mercury, while greater 
than that of the control animals, was smaller than 
that obtained after treatment with dimercaprol. 
Calculating the quantities excreted after twenty - 
four hours as the percentages of the mercury absorb- 
ed, the mean for the control animals was 15%, for 
the animals treated with dimercaprol 55 %, and for 
those treated with the glucoside 29%; all these 
differences were significant (P < 0.01). This 
comparatively small increase in the excretion of 
mercury after treatment with dimercaprol glucoside 
was surprising, and the effect of reducing the dose 
of mercuric chloride was investigated. Only a 
limited decrease in the dose was possible owing to 
the increased error which resulted from lowering the 
counts obtained from samples. Accordingly, the dose 
of mercuric chloride was reduced to 3.7 W. /kg. 
(0.75mg. Hg. /kg.), and the animals were treated with 
dimercaprol/ 
40. 
dimercaprol glucoside as previously (Tables 8, 9, 
and 10). In these cases, smaller fractions of the 
dose were generally found in the erythrocytes, and 
larger fractions in the urine, than in the cases of 
animals receiving 51-IM. /kg. of mercuric chloride. 
However, the difference between the actual weights 
of mercury excreted by the two groups was not signifi- 
cant. 
Rabbit 409 (Table 10) was injected with 3.71,1M./ 
kg. of mercuric chloride, and was not treated; the 
urinary excretion of mercury amounted to 23% of the 
dose, whereas that of the control animals receiving 
5µ1. /kg. was 15;. This increased excretion was 
probably mainly due to the smaller quantity of 
mercury remaining at the injection site, and not to 
the reduction in the dose. One rabbit (No.407) 
was given dimercaprol glucoside in three equal doses, 
instead of one large dose followed by a smaller one. 
There was no alteration in the quantity of mercury 
excreted. A further experiment (rabbit No.405) con- 
firmed the excretion figures, after dimercaprol 























































































































































































































































































































































































































































































































































































































































































































FIG. 3Q. FIG. 3 b. 
FIG. 3C. 
Fig. 3 (a). The mean concentrations of mercury 
in various tissues and organs twenty- 
-four hours after the intravenous 
administration of 5/UK./kg. of mercuric 
chloride. 
Fig. 3 (b). The mean concentrations of mercury 
in various tissues and organs twenty- 
-four hours after the intravenous 
administration of 5 ,pti /kg. of mercuric 
chloride and subsequent treatment 
with dimercaprol. 
Fig. 3 (c). The mean concentrations of mercury 
in various tissues and organs twenty- 
-four hours after the intravenous 
administration of 5 1 M. /kg. of mercuric 
chloride, and subsequent treatment with 
dimercaprol glucoside. 
< 04 »7/7 
_ . _._ 0.4- 1.0/U.7. 7 
-- ---- 1'0 -50A0 y 
_ _ _ _ _ _ . 5.0 - 15.0/1 7. 
______ 15.0- 30.00.7 7 
93 :8'r e933 3;111:111111 3933i6 11111 
NORM e::.: e::: ié!!éé9 
The cumulative excretion of mercury in the urine during 24 hours 
after the intravenous injection of 5»M/kg. of mercuric chloride, 
expressed as the percentage of the mercury absorbed. The individual 
observations are plotted. 
CONTROLS 
TREATED WITH DIMERCAPROL 



















4 8 12 16 20 24 
TIME IN HOURS AFTER INJECTION OF MERCURIC CHLORIDE 
42. 
The main changes in the tissue distribution of 
mercury, after treatment with dimercaprol or dimer- 
caprol glucoside, are illustrated in Fig.3. The 
concentrations of mercury found in the various 
tissues are depicted, and were calculated as the 
average of the figures obtained in those animals 
killed at the end of the twenty -four hour period. 
A summary of the mean percentages of the dose found 
in various tissues is given in Table 11. 
The cumulative excretion of mercury in the urine 
during twenty -four hours without and with treatment 
by dimercaprol or dimercaprol glucoside, is illus- 
trated in Fig.4. The percentages of the absorbed 
mercury have been calculated, and the ranges covered 
by the individual observations at twenty -four hours 
are shown. 
In these diagrams, the results tend to be over- 
simplified, but it is considered that this is justi- 





























































































































































































































































































































































































































































































































































































































PART II. Gold. 
In view of the short half -life of Au198, 
of the inconveniences of supply, and the satisfact- 
213 
ory results repeatedly obtained with Pb , the tech- 
nique of ashing and estimation used for the latter 
was applied, without preliminary checking, to studie- 
on the former. Consistently poor recoveries indi- 
cated that considerable losses of gold occurred 
during this procedure. Possibly volatilization of 
the gold took place through overheating, for Block 
and Buchanan (1940) emphasize that gentle heating is 
necessary during the ashing of tissues containing 
gold. The pertinent recovery experiments with 
mercury (vide p.24 ) had not been carried out at the 
188 
time of this work, and the short half -life of Au 
precluded extensive investigations into the cause of 
the losses. 
Nevertheless, the error of the duplicate esti- 
mations was only 8ó, which indicates that approxi- 
mately similar proportions of gold were lost from 
each sample. Thus, the true relative amounts of 




same as found in these experiments, but the actual 
concentrations of gold are likely to be higher. 
Again, urine and bile samples were not ashed, and 
hence were not subject to this loss of gold. 
Results are presented showing the distribution 
and excretion of gold in eight rabbits, all of which 
received a single dose of 0.07mM. /kg. (1.97mg. Au /kg.) 
of gold chloride intravenously, and were killed twenty - 
four hours or five days after the administration of 
gold. Four of the rabbits received treatment with 
dimercaprol, as detailed in Tables 12 and 13. No 
ill effects were noted, except in the case of rabbit 
No.387 in which mild convulsions occurred after the 
first injection of dimercaprol. 
The concentrations of gold in microgrammes per 
gramme of tissue and the percentages of the dose in 
various organs and tissues are presented in Tables 
12 and 13. After twenty -four hours, a large pro- 
portion of the gold was still circulating in the 
blood, mainly in the plasma, of the control animals. 
Very high concentrations were found in the spleen. 
The kidneys contained the next highest concentration, 
about 8 -1211g. of gold per gramme, while the liver 
held/ 
46. 
held only 2 -411g. per gramme and accounted for about 
3% of the dose. The bile contained 2 -511g. of gold 
per ml. and, on the limited information obtained, 
the gastro- intestinal tract and its contents held an 
average of about 111g. per gramme. Bone marrow con- 
tained 4 -84g. of gold per gramme, and accounted for 
4 -8b of the dose; the concentration in bone was 
lower, the epiphyses containing 1 -211g. and the dia- 
physes roughly lµg. per gramme. The very high con- 
centration of gold in the sample of skull vault from 
rabbit No. 201 seems anomalous. The lungs contained 
1 -44g. of gold per gramme, while heart and brain held 
only very small quantities. The concentrations in 
skin and skeletal muscle were also low, but accounted 
for 10 -20% of the dose. 
Only 3 -8% of the gold administered was excreted 
in the urine in twenty -four hours, and less than 1% 
in the faeces. After five days, urinary excretion 
still accounted for only 8% of the dose, but 10% was 
found in the faeces over that period. Details of 
the excretion of gold in this experiment are given 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Much smaller concentrations of gold were detect- 
ed in the spleen, blood, bile, bone marrow and bone 
after the five -day period. The concentrations in 
the liver, kidneys, lungs and skeletal muscle 
remained fairly constant. It should be noted that 
l0% of the dose was retained at the injection site 
in this rabbit (No.203). 
The results of treatment with dimercaprol are 
also presented in Tables 12 and 13. The most 
significant effect was a decrease in the concen- 
trations of gold in the blood after twenty -four 
hours, the amounts in both plasma and erythrocytes 
being approximately halved. The concentrations of 
gold in the bile increased but there was no observ- 
able effect on the gold content of other tissues. 
No explanation can be offered for the very high con- 
centration of gold found in the epiphyses of rabbit 
No.211. 
The excretion of gold in the urine was approxi- 
mately doubled after dimercaprol treatment, but there 
was no effect on the faecal excretion. 
Even when treatment was delayed until two days 
after the administration of gold, dimercaprol still 
caused/ 
50. 
caused an increased urinary excretion of the metal. 
analler amounts of gold were found in the blood, 
liver, kidneys, and skeletal muscle of the treated 
rabbit than in the control animal, and larger 
quantities occurred in bone and bone marrow. As 
some of these effects are at variance with those 
found after the twenty -four hour period, and only 
one set of results is available for the five -day 
period, the differences cannot be definitely 
ascribed to the action of dimercaprol. The effect 
of treatment on the excretion of gold in the urine 
in the five -day experiment is illustrated in Fig.5, 
and details of the urinary and faecal excretion are 
given in Table 14. 
To ensure that no large amounts of gold 
occurred in sites which were not usually sampled, 
the gold contents of various additional tissues in 
rabbits Nos. 202 and 212 were estimated. The 
results are shown in Table 15. None of these 
tissues contained any notable concentrations of 
gold, and a reduction in the concentrations appeared 
to occur in most of there after treatment with 
dimercaprol. 
Table 14/ 
The concentrations of gold found 
intravenous injection of 0.01 mM. /kg. 
represents the injection of propylene 
dimercaprol. 
in samples of urine after the 
of gold chloride. Each ar ow 
glycol or of 25 mg. /kg. of 
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The concentrations of gold in certain 
additional tissues of rabbits 24 hours after 
the intravenous administration of O.Olirvi. /ug. 


















5O w.1g. dimercaprol 
at 19 hours, and 




µg. Au per g. fresh 














PART III: Lead. Acute distributions. 
Results are presented for the distribution 
and /or excretion of lead in twelve rabbits, all of 
which received a single intravenous dose of 0.07mI./ 
kg. of lead acetate. Two of these rabbits received 
no further treatment, and six were treated with 
dimercaprol glucoside, as set out in Tables 16 and 
17. One animal was treated with dimercaprol, two 
with 1:3- dimercaptopropanol, and one with 1:4 -di- 
thioerythritol, and the results are shown in Tables 
19 and 20. 
A further series of seven rabbits received a 
single intravenous dose of O.lmM. /kg. of lead 
acetate, and three of these were treated with di- 
mercaprol and three with dimercaprol glucoside. 
Observations were made on the lead contents of blood, 
kidneys, and urine only, and the results obtained 
are given in Table 13. 
All these animals were killed twenty -four hours 
after the administration of lead acetate. 
The concentrations of lead in microgrammes per 
gramme of tissue and the percentages of the dose 
found/ 
54. 
found in various tissues and organs are shown in 
Tables 16 and 17, for those animals which received 
0.01mM. /kg. (2.07mg. Pb /kg.) of lead acetate, without 
and with treatment with dimercaprol glucoside. This 
dose of lead is well below the toxic level, and the 
animals appeared quite healthy up to the time of 
death. 
i 
Despite the variation occurring between animals 
treated in the same way, the following trends can be 
seen. 
The control animals which received 0.01mM. /kg. 
of lead acetate provided results which are generally 
consistent with those obtained by Ginsburg and 
Weatherall (1948), using a similar method. The 
main differences are that higher concentrations of 
lead were found in the kidneys in these animals, and 
a larger amount of lead was excreted in the urine, 
1 -4ó as against 0.2 -110. It is probable that these 
differences can be attributed, at least in part, to 
the rate of injection of lead. Weatherall (personal 
communication) states that rapid injections of lead 




High concentrations of lead. 18 -2211g. per gramme, 
occurred in the liver, which contained about 30% of 
the dose, and in the spleen, bone marrow, and epi- 
physes. Concentrations of 2 -6µg. of lead per 
gramme were found in diaphyses, lungs, bile, and 
erythrocytes. The colon and small intestine con- 
tained leas than lµg. per gramme, but the concen- 
tration of lead was slightly higher in the gut con- 
tents. skin, skeletal muscle, and plasma held only 
very small amounts of lead. 
The experiments of Ginsburg and Weatherall 
dealt comprehensively with the effect of dimercaprol 
on the distribution of lead in rabbits after an intra- 
venous dose of O.OlmM. /kg. of lead acetate. For 
this reason, only one rabbit in the present studies 
was treated with dimercaprol (vide infra). 
The administration of dimercaprol glucoside 
caused several changes in the distribution of lead. 
Decreases in the amounts of load in the liver and 
erythrocytes were found. The quantities of lead 
in bone and kidneys also tended to decrease, but 
these changes were not very significant. The 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































excretion of lead, accounting for most of the metal 
lost from the tissues. A large increase in the 
biliary excretion of lead also occurred, about 
0.6 per cent of the dose being found in the bile 
from the gall bladder, as compared with 0.1 per 
cent in the case of the control animals. The con- 
centrations of lead in other tissues were not 
altered to any significant degree by dimercaprol 
glucoside treatment, nor was the faecal excretion 
affected, though a longer period of observation 
might have disclosed an increase, considering the 
enhanced biliary excretion of lead. The high con- 
centrations of lead found in the lungs of rabbits 
Nos.382 and 383 were possibly due to the formation 
of some particular matter in the injection solution, 
with subsequent deposition of these particles in the 
lungs. 
The main changes occurring after dimercaprol 
glucoside treatment are summarised in Fig.6. The 
concentrations of lead shown for the different 
organs and tissues, are the mean figures for both 
control animals and for all the animals receiving 




Fig. 6 (a). The mean concentrations of lead in 
various tissues and organs twenty -four 
hours after the intravenous administrat- 
ion of 0.01 mM. /kg. of lead acetate. 
Fig. 6 (b) The mean concentrations of lead in 
various tissues and organs twenty -four 
hours after the intravenous administrat- 
ion of 0.01 mM. /kg. of lead acetate, an 




results, since early treatment with the glucoside 
caused a greater decrease in the lead content of the 
bones, and a greater increase in the urinary excre- 
tion of lead, than did late treatment. 
The effect of treatment with dirnercaprol was 
investigated in one experiment (rabbit No.377), 
sampling only those tissues containing high concen- 
trations of lead in the control animals. The 
results are shown in Tables 19 and 20, and are con- 
sistent with those obtained by Ginsburg and Weather- 
all (1948). The main differences between the 
effects of treatment with the two dithiols, are the 
greater quantities of lead found in urine and bile 
after administration of the glucoside. It is 
difficult to determine from which tissues this 
increased loss of lead occurs, owing to the vari- 
ation shown by the animals. 
An intravenous injection of 0.lmM. /kg. 
(20.7mg. Pb /kg.) of lead acetate is close to the 
median lethal dose for rabbits. The animals 
poisoned with this quantity of lead showed signs of 
considerable renal damage. All samples of urine 
contained/ 
60. 
contained quantities of casts, and haematuria 
occurred in some cases. The kidneys of the 
latter animals showed haemorrhagic areas. There 
was no relationship between the incidence of 
haematurta and the treatment given. Varying 
degrees of haemolysis were found by inspection 
of the plasma. 
The distribution of lead after this dose of 
lead acetate is similar to that found after a dose 
of 0.01mL?. /kg., except that a higher proportion of 
the dose tends to occur in the bone marrow, and 
a smaller proportion in the erythrocytes ( Weatherall, 
personal communication) . The quantities of lead 
found in the blood, of the one untreated animal 
(rabbit 427) are similar to the figures given by 
Weatherall, but the amounts in the kidneys and urine 
are somewhat higher (Table 18). 
The results obtained from rabbit 423, which . 
was treated with dimercaprol at one and five hours 
after the administration of lead acetate, are quite 










































































































































































































































































































































































































































































































































































































































































































































explanation can be offered for this finding. If 
this set of results is ignored, then a close simi- 
larity is found between the effects of dimercaprol 
and dimercaprol glucoside treatment. The excretion 
of lead in the urine was increased to 3 -4 times that 
of the control animal. The concentrations of lead 
in the erythrocytes and the kidneys was decreased. 
Although a smaller percentage of the dose was 
excreted than that obtained after administration of 
the smaller dose of lead acetate, with similar treat- 
ment, the actual weight of lead in the urine was 
higher - about 2mg. as compared with 0.2- 0.5mg. 
The results indicate that the effectiveness of 
dimercaprol glucoside in promoting the urinary 
excretion of lead was diminished to a larger extent 
by the increased dose of lead acetate than was that 
of dimercaprol. The significance of this finding is 
discussed later. 
In two additional experiments (rabbits Nos.428 
and 429), 1:3- dimercaptopropanol or 1:4- dithio- 
erythritol were administered at one hour and five 
hours after the injection of 0.0lnN /kg. of lead 




blood, kidneys, and urine were studied, since these 
experiments were carried out mainly to test the 
ability of the dithiols to promote the urinary 
excretion of the metal. The results are presented 
in Tables 19 and 20. Both substances increased the 
excretion of lead, but 1 :4- dithioerythritol tended 
to be less effective than dim.ercapro.l. The rabbit 
treated with 1:3- dirnercaptopropanol, however, 
excreted a larger percentage of the dose of lead 
than did any other animal in the present series of 
experiments. Nearly 42 of the dose was found in 
the urine of this animal, in spite of the very small 
dose which, because of the high toxicity of 1:3-dimer- 
captopropanol, was given. It should be noted that 
the excretion figures for the control animals (Table 
17) were 1% and 4 of the dose. 
This experiment was repeated (rabbit No.430) and 
this time about 27e of the dose occurred in the urine. 
Even this result compares favourably with those 
obtained after treatment with dimercaprol glucoside, 
and in the latter case 7 -8 times the number of mole- 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Little information is available to show from 
which tissues this loss of lead occurred, but appar- 
ently the lead in the erythrocytes was not decreased 
as it was in the animals treated with dimercaprol or 
dimercaprol glucoside. The lead content of the 
.cidneys was smaller than that of the untreated animals, 
and the lead in the plasma remained of negligible 
quantity. 
The urine of rabbit No.428 contained casts pre- 
sumably due to the high concentration of lead which 
must have passed through the renal tubules, but the 
kidneys themselves were of normal appearance. Apart 
from this, rabbit No.428 showed no signs of toxic 
effects, but rabbit No.429 developed tremors, becoming 
almost mild convulsions at times, after the first 
injection of 1:4- dithioerythriol. One rabbit (not 
otherwise reported) developed convulsions and died 
within thirty minutes after an injection of 150mg. /kg. 
of 1:4- dithioerythriol, (twice the dose administered 
to rabbit No.429). 
67. 
LEAD: sub -acute distributions. 
The following experiments were carried out 
in collaboration with Dr. M. Ginsburg and Dr. M. 
Weatherall, and have already been published (Adam, et 
al. 1949). 
Results are presented for the distribution and 
excretion of lead in seven rabbits, all of which 
received, by intravenous injection, a single dose of 
lead acetate containing 2.07mg. of lead per kg. of 
body weight. some of the rabbits were treated with 
dimercaprol or with parathyroid extract or with both, 
as indicated in Table 21, and all were killed after 
twenty -one days. The parathyroid extract, which is 
believed to mobilize lead from bones (Hunter and Aub, 
1927), was given in the morning. The dimercaprol 
was given at the sane time, though injected at a 
different site, and again four hours later, in order 
to cover the period in which the greatest mobilization 
of lead might be expected. 
The concentration of lead in microgrammes per 
gramme of wet weight of tissue and the percentage of 
the dose found at death (i.e., three days after the 
end of treatment) in various organs and calculated 
for/ 
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for various tissues are shown in Tables 21 and 22. 
Only one portion of the intestine, the colon, was 
sampled. The rest of the alimentary canal was the 
largest amount of tissue not examined in these 
animals, but probably did not contain more than 1 
or 2 per cent of the dose. 
Of the lead which remained in the body, regard- 
less of treatment and apart from that which remained 
at the site of injection (notably rabbit 399), 60 
to 95 per cent was found in the bones. No other 
single tissue accounted for more than a few per cent 
of the dose, and only the liver and bone marrow con- 
tained more than 2 per cent consistently. Similarly, 
the highest concentrations were found in the bones, 
bone marrow, and liver, which generally contained 
1 -10yg. of lead per g. of tissue. Other tissues 
rarely contained more than 1}ßg. per g. The concen- 
trations in blood cells, lungs, kidneys, bile from 
the gall bladder, and skin tended to be above 0.111g. 
per g. whereas those in skeletal muscle, the aliment- 
ary canal, and brain tended to be below this level. 
Inspection of the results shows no striking 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































concentrations in bone were higher in the untreated 
animal than in any others. Interpretation of this 
difference is confused by the variability of the 
concentration in different bones, by the large deposit 
of lead at the site of injection in rabbit 399, and by 
the variation in the amount of lead excreted before 
treatment was started. Since the treated animals 
did not show any definite increase in the amount of 
lead outside the skeleton, the evidence that appreci- 
able quantities of lead was removed from the bone by 
any of the treatments is unconvincing. Other tissues 
showed no consistent differences which could be 
related to the treatments. 
The amounts of lead excreted before and after 
treatment are shown in Table 22. Faecal excretion 
was generally two to three times greater than the 
urinary excretion, and the amounts of lead eliminated 
appeared to depend to some extent on the quantity of 
excreta passed. Treatment with dimercaprol on the 
fifteenth and subsequent days after the administration 
of lead, was followed by an increase in the concen- 
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Fig. 7. 
The effect of dimercaprol and parathyroid extract 
on the excretion of lead in the urine and faeces 
15 -18 days after the intravenous administration of 
lead acetate (2.07 mg. Pb /kg). 
Ordinates: Amount of lead excreted as a 
percentage of the dose administered (1 per cent= 
20.7 pg. Pb /kg. body weight). Abscissae: Number 
of days after the injection of lead acetate . D= 
12.5 mg. /kg. dimercaprol injected intramuscularly. 
P = 8 units /kg. parathyroid extract injected 
intramuscularly. 
URINARY EXCRET ION. 
FAECAL EXCRETION. 
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accompanied by a reduction in the quantity of 
excreta, so that there was no increase in the total 
amount of lead excreted. ra slight fall of doubt- 
ful significance occurred in the total quantity of 
lead excreted by the rabbits treated with parathyroid 
extract or with dimercaprol and parathyroid extract, 
probably owing to the decrease in the quantity of 
excreta which also occurred in these rabbits. 
Rabbit 399 developed acute retention of urine during 
the days preceding death, when over 400m1. of urine 
was found in the bladder. No cause for this reten- 
tion was apparent, but it accounts for the large 
amount of lead recorded as excreted on the twenty- 
first day. 
T'ne effects of the treatments on the elimination 




The method used in these experiments is 
simple in principle, and the estimations, as com- 
pared with chemical analyses, are rapid and sensi- 
tive. These advantages afforded by the use of 
radio- active isotopes are well known. Nevertheless, 
there are certain disadvantages which must be con- 
sidered; and the extensive sampling of tissues, 
and the slow rate of ashing, rendered the work 
laborious and tine- consuming. 
The effect of the radiations emitted by the 
isotopes on the animals used in these experiments is 
unknown, but the possibility exists that some effect 
did occur. However, the general similarity between 
the results obtained here and those of previous 
workers who had used chemical methods indicates that 
any such effect must have been small. 
A further disadvantage is that isotopes with 
short half -lives limit the lengths of the distri- 
bution periods which can be investigated. 
Fortunately,/ 
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Fortunately, in the case of lead, the slowly- decaying 
isotope radium D was available for use in the distri- 
bution periods of more than one day; but no isotope 
of gold, other than AU , is available and the maxi - 
mum distribution period which can be attempted is 
about a week. The period could be extended by 
increasing the activity of the injection solution, 
but this would afford a greater risk of radiation 
effects in the animals. 
A new technique which has been reported recently 
(Tobias and Dunn, 1949) obviates these difficulties. 
This method involves the neutron irradiation of ashed 
samples taken from poisoned animals in the usual 
manner. In this way, the metal is rendered radio- 
active, and available for estimation, after the animal 
has been killed. The distribution period can be as 
long as desired, since only the stable element is 
administered to animals. However, the method requires 
permanent access to a pile, and facilities for the 
radio -chemical separation of the element. 
Data concerning the distribution and excretion 
of a poison under the influence of an antidote may 
provide considerable information regarding the way 
in/ 
75. 
in which the antidote acts. Excretion of the poison 
may be promoted or its transfer to less susceptible 
tissues facilitated. 
Such results are conditioned to a large extent 
by variables such as dosages and routes of admini- 
stration of poison and antidote, the periods over 
which observations are made, and the delay between 
poisoning and initiation of treatment. Furthermore, 
large variations occur between animals treated in the 
same way. A satisfactory investigation, demon - 
strating the effects of these variables, would involv 
the use of large numbers of animals and considerable 
time and labour. From this point of view, the 
present work is incomplete. 
In describing the changes occurring after the 
administration of the antidote, it should be remem- 
bered that part of these effects may be due to 
actions of the antidote on the animals. No doubt 
the changes mainly depend on the relative dissoci- 
ability of the compounds formed between the metal and 
tissue constituents and between the metal and the di- 
thiol, and on the subsequent behaviour of the metal - 
dithiol/ 
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dithiol compound. The former factor will be influ- 
enced by the concentration of dithiol in any given 
tissue, but no data are available on the distri- 
butions of the dithiols in the present experiments. 
With due recognition of these points, the 
results of the present series of experiments have 
afforded certain conclusions which are discussed in 




The literature describing the distribution 
and excretion of mercury in animals is small in 
quantity, and meagre in information. Very small 
amounts of the soluble compounds of mercury kill 
animals within a short period of time, and hence a 
sensitive analytical method is necessary. A satis- 
factory and fairly comprehensive study of the distri- 
bution of mercury in human cadavers after death from 
mercuric chloride poisoning, was made by Sollznann and 
Schreiber (1936). In these cases, ofcourse, compara- 
tively large quantities of mercury were available for 
estimation. They reported that mercury could be 
found in the following sites, in order of decreasing 
concentration: kidneys, liver, spleen, intestine, 
lungs, heart, skeletal muscle, brain, blood. Very 
little mercury was excreted, for in such fatal cases 
anuria develops early in poisoning. 
Lomholt (1924) investigated the distribution and 
excretion of mercury in rabbits, after giving a series 
of intramuscular injections of mercuric benzoate, 
mercuric salicylate, calomel, or metallic mercury. 
Only one rabbit was studied per compound, and the 
animals were killed a variable number of days after 
the/ 
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the administration of mercury. Large quantities of 
the mercury were unabsorbed, but the most soluble 
compound, mercuric salicylate, gave the following 
results after nine days: 29% of the dose excreted, 
and 34% unabsorbed; the kidneys held much the high- 
est concentration of mercury, followed by liver, 
intestines and contents, lungs, and blood, in that 
order. 
Young et al. (1930) also studied the distribution' 
of mercury in rabbits after the administration of mer- 
curic salicylate, but gave very scanty data. They 
reported that 'during active excretion' the quantities 
of mercury in the tissues occurred in this order of 
decreasing concentration: bone, skeletal muscle, 
kidneys, liver; and 'after active excretion': bone, 
liver, skeletal muscle, kidneys. In the latter case, 
bone contained by far the highest concentration of 
mercury. No data regarding dosage and raute of 
administration, or a definition of the term 'active 
excretion' were given. 
Literature containing older analyses was 
unfortunately inaccessible, but Solimann and Schreiber 
(1936) quote Lomholt (1928) as describing, in a review 
of/ 
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of the fate of mercury in the body, a similar general 
distribution to that which they had found. 
The radio- active tracer method is well suited to 
application in such a problem as this, where only 
minute quantities of a substance are available for 
estimation. Although the mercury used was of com- 
paratively low specific activity, quantities of the 
order of O.l1.1g. in an average sample could be detect- 
ed. This enabled extensive and accurate investi- 
gations of the fate of a single intravenous dose of 
mercuric chloride to be made. 
The results are largely in accord with those 
obtained by Lomholt, and by Sollmann and Schreiber, 
described above. Quantitative differences occur 
because of higher doses and slower rates of absorp- 
tion in the studies of these authors. The only 
qualitative differences are that Sollmann and 
Sohreiber found larger amounts of mercury in the 
heart and spleen, but this may be related to the 
route of administration. 
The observations of the present studies are not 
consistent with the data of Young et al. (1930). 
These authors suggested that the distribution of 
mercury/ 
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mercury was very similar to that of lead, but the 
results shown in Tables 2 and 16 indicate that these 
elements differ markedly in their affinities for 
particular tissues. For instance, lead was found 
to concentrate in the bone, bone marrow, and spleen, 
whereas only small quantities of mercury occurred in 
these sites. 
The slow excretion of mercury, predominantly in 
the urine, has been noted in all these works, as well 
as in the present studies where less than two- thirds 
of the dose of mercury was excreted in two weeks. 
The striking decreases which occurred in the 
concentrations of mercury in the kidneys after treat- 
ment with dimercaprol, account for the diminished 
renal injuries noted by Ginzler (1946) and by Gilman 
et al. (1946a). These authors found that delay in 
treatment greatly decreased the protection afforded 
to the kidneys by dimercaprol, yet the present experi- 
ments show that the quantities of mercury in the 
kidneys are still diminished by treatment begun 
several days after poisoning. Presumably after a 
time depending on the dose of mercury, irreversible 
changes take place as the result of the prolonged 
contact/ 
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contact of the mercury with susceptible enzymes, and 
the lesion romains although the mercury is removed. 
This decrease in the concentration of mercury in 
the kidneys has also been reported very recently by 
Fitzsimmons and Kozelka (1950) who administered 10mg. 
of mercuric chloride to Rhesus monkeys by the oral 
route, and 0.5mg. /kg. of mercuric chloride intra- 
peritoneally in rats, and subsequently treated the 
animals with dimercaprol. These authors state that 
the mercury contents of other tissues were raised 
after dimercaprol, but do not give any details. They 
also found that the rats excreted more mercury in the 
urine after treatment with dimercaprol, but that the 
faecal excretion was unchanged. 
This increased urinary excretion of mercury was 
found in the present work, and it occurred even when 
treatment was delayed until nine days after the admin- 
istration of mercuric chloride. This effect suggests 
that dimercaprol therapy might prove beneficial in 
more chronic types of mercury poisoning. Evidence 
was obtained that the increase in the excretion of 
mercury was transient in spite of continued treatment, 
but possibly intermittent courses of dimercaprol 
therapy/ 
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therapy might induce repetitions of the initial 
effect. 
The fact that continued treatment does not 
maintain a supra -normal excretion of mercury although 
a considerable amount of the metal remains in the 
body, indicates that the mercury fixed by the 
tissues can be divided into two categories. One 
section of the mercury is comparatively labile, and 
readily leaves the tissues to combine with dimer- 
caprol; the other section must form a less readily 
dissociated compound with some tissue constituent. 
This raises the possibility of an alternative chemi- 
cal configuration which would form a more stable com- 
pound with mercury than does dimercaprol. 
Gilman et al. (1946a) have shown that dimercaprol 
can react with mercuric chloride in vitro to form at 
least two different complexes. From a consideration 
of the molecular proportions in which the substances 
combined, the following formulae were suggested: 
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The latter compound was soluble, and was con- 
sidered to be the more likely of the two to occur in 
vivo. It was also stated that the second compound 
was more stable than the first. This is surprising, 
since dithiols form more stable cyclic compounds 
with arsenic than do monothiols, which would form 
just such an open -chain structure as is suggested 
for the second complex. However, it is difficult 
to present any suitable alternative formulae. 
These workers also found that the toxicity of 
the second complex, when administered to rabbits, 
was equal to that of mercuric chloride. Obviously, 
the excess of dimercaprol usually administered in 
mercury poisoning must diminish this toxicity in 
some way. The effect is reminiscent of that of the 
dimercaprol oxophenarsine compound, which has a 
toxicity equal to that of oxophenarsine itself, but 
if additional dimercaprol is administered the tox- 
icity is reduced to one -fifth (Peters and Stocken, 
1947). The latter authors ascribe this effect to 
suppression of the dissociation of the dimercaprol- 
oxophenarsine compound by excess dimercaprol. Gilman 
et/ 
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et al. on the other hand, believe that the corresp- 
onding effect with mercury is due to the additional 
dimercaprol reacting with mercury released from the 
complex by intracellular oxidation of dimercaprol. 
However, the evidence for such destruction of dimer- 
caprol is controversial (Webb and van Heyningen, 
1947; Barron et al. 1947). 
upport was given to the hypothesis of Gilman 
et al. by the toxicities of the compounds formed by 
dimercaprol glucoside and mercury. These compounds 
result from similar in vitro reactions' to those 
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The toxicity of the first complex is about half, 
and that of the second about one -eighth that of mer- 
curic chloride. Yet the mercury dissociates more 
readily from this first complex than from the second 
dimercaprol/ 
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dimercaprol compound. Gilman et al, suggested that 
this was due to the extracellular distribution of 
the glucoside, with consequent immunity to oxidation. 
The results reported here support to some 
extent the hypothesis of such a distribution of di- 
mercaprol glucoside. The mercury level in the 
plasma was consistently raised after treatment with 
the glucoside, but not after dimercaprol therapy. 
It is difficult, however, to describe the increased 
biliary excretion of mercury as an extracellular 
effect. 
Further evidence on this hypothesis is not 
given by the present studies, since the distributions 
of the preformed complexes were not studied. 
Considering the size of the dose, and the water - 
solubility, of dimercaprol glucoside, it is surpris- 
ing that the excretion of mercury in the urine after 
treatment with this substance was less than that 
obtained after dimercaprol therapy. It was consid- 
ered that the initial large dose of dimercaprol 
glucoside might possibly have directed mercury to 
the kidneys in such high concentrations that damage 
resulted; but in one experiment (rabbit 407) the 
treatment was altered so as to give three similar 
medium -/ 
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medium -sized doses of the glucoside, but this did not 
alter the quantity of mercury excreted. It should 
also be noted that when dimercaprol glucoside was 
administered immediately after the mercury, the 
quantities of metal in the urine after one hour were 
slightly higher than those obtained after dimercaprol 
treatment at corresponding times. 
Possibly some type of renal damage occurs within 
an hour after the administration of mercury, and can 
be alleviated by dimercaprol but not by dimercaprol 
glucoside treatment, but this conception has little 
factual support. 
Nevertheless, Gilman et al. (1946a) found dimer- 
caprol glucoside to be as effective an antidote in 
mercury poisoning as was dimercaprol, in equimo lecular 
doses. As even larger doses of mercury were admini- 
stered in those experiments, it must be assumed that 
the mercury retained in the plasma by dimercaprol 
glucoside is as effectively non -toxic as if it had 
been excreted in the urine. Possibly this plasma 
mercury would have been found to diminish, and the 
metal excreted in the urine increased, had the observ- 
ations been prolonged beyond 24 hours. In any case, 
the 
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the fact that the plasma mercury was maintained at 
that level suggests that either the complex was 
attached to plasma proteins, or else that the renal 
tubules tended to reabsorb it. Experiments 
studying the renal clearance of mercury under these 




In the case of gold, there is rather more 
information available regarding the tissue distri- 
bution of this element, possibly because compara- 
tively large amounts of gold can be administered to 
animals without causing serious toxic effects and the 
chemical methods of analysis appear to be quite sat- 
isfactory. 
Orestano (1932) injected 19mg. of gold /kg. as 
gold chloride, intravenously in rabbits, and after 
five days found 3mg. of gold in the kidneys, 0.5mg. 
in the liver, 0.4mg. in bone marrow, 0.2mg. in the 
spleen, and only a trace in the lungs. Leulier and 
Béruard (1938) reported distributions of gold in 
rabbits over various periods, from a few minutos to 
one month after the intravenous injection of 40mg. 
of gold /kg. The liver, spleen, and lungs contained 
large amounts of gold at first, but the concentration 
in the lungs decreased very rapidly. Only small 
quantities of gold occurred in the kidneys, and very 
little in the plasma. The smaller gold content of 
the kidneys, as compared with Orestano's findings, 
may/ 
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may be related to the different compound of gold used 
(calcium aurothioethanesulphate). 
Block et al. (1941, 1942) administered lmg. of 
gold, in the form of various therapeutic preparations 
per day for fourteen days to rats by intramuscular 
injection. One day after the last injection, high 
concentrations of gold were found in the kidneys, 
liver, and spleen, and only small amounts in the lung 
and heart. Considerable quantities of gold remained 
in the plasma, but none could be detected in the bloo 
cells. 
198 
The radio- active isotope, Au 
utilised previously to trace the tissue distribution 
of gold. Ely (1940) administered gold chloride, con- 
198 
taming Au , to rats by the oral, intraperitoneal 
and subcutaneous routes. Very little absorption 
occurred from the intestine during the first 24 hours 
but within three days most of the dose had been 
absorbed, and a large proportion was found in the 
kidneys. The adrenals, lungs, lymph nodes, liver 
and spleen also contained rather large amounts of 
gold, but very few details were given and only four 
animals/ 
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animals were investigated. 
Thirty days after the intravenous injection of 
10mg. of gold, as gold sodium thiosulphate, in a 
mouse, concentrations of 0.4mg. of gold per g. to 
0.005 -.g. per g. were found in the following tissues 
in order of decreasing magnitude: liver, ovaries, 
thymus, adrenals, lungs, lymph nodes, spleen, kidneys, 
heart, bone, pancreas, skin, gall bladder, tendon, 
muscle, blood cells, brain, gut, plasma. A recovery 
of 23¡% of the dose was obtained, and the rest of the 
gold was assumed to have been excreted (Tobias and 
Dunn, 1949) . 
The excretion of gold is generally slow. Leulier 
and Beruard, in the experiments quoted above, found 
only 8% of the dose excreted in the urine in 25 days. 
After the administration of 50mg. of gold, as auro- 
thioglucose, to a patient, about 14% of the dose was 
excreted in the urine in 7 days, and about 4% in the 
faeces (Kent and McCance, 1941) . Clinical reports 
state that about 20% of the dose is excreted in a 
week after the administration of 100mg. of gold, but 
that excretion may continue for several months (Frey- 
berg et al. 1943; Comroe, 1945). 
Rats/ 
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Rats appear to excrete gold more readily than 
do rabbits or humans, for Block et al. (vide supra) 
reported urinary excretions of 68% of the dose after 
administration of sodium succimidoaurate and 4l;ó 
after gold sodium thiosulphate. Less soluble gold 
compounds, such as gold calcium thiomalate, tended . 
to be excreted more in the faeces than in the urine. 
The present experiments indicated that, in 
rabbits, about as much gold was excreted in the 
faeces as in the urine a few days after the injection 
of gold chloride. They also confirmed the slow rate 
of excretion of gold in this species. The results 
of the tissue distributions are in general agreement 
with those obtained by previous workers. The concen- 
trations of gold in the plasma are notably high, as 
found by Block et al. (1941), but in contrast to the 
findings of Leulier and Beruard (1938) and Tobias and 
Dunn (1949). 
The low recoveries, and their possible cause, 
obtained in the present experiments have been dis- 
cussed already. For two reasons, it is felt that 
the results are not so marred by the poor recoveries 
as to prohibit their inclusion in this thesis. They 
are 
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are not incompatible with previous work on untreated 
animals. The error of the duplicate estimations is 
sufficiently low to suggest that similar fractions 
of gold were lost from each sample; therefore the 
results from treated and untreated animals are likely 
to be comparable, fulfilling the main purpose of the 
experiments. Nevertheless, it is desirable that the 
work should be repeated when the cause of the loss of 
gold has been determined. 
The changes occurring after the administration 
of dimercaprol consisted mainly of a decrease in the 
gold content of the blood and an increase in the 
urinary excretion of the element. The excretion was 
almost doubled, but still consisted of only 6 -9¡ of 
the dose after twenty -four hours. This effect has 
also been noted by Kuzell et al. (1948), after intra- 
venous administration of gold sodium thiosulphate or 
gold chloride in rabbits, and subsequent treatment 
with dimercaprol. 
Unfortunately, dimercaprol glucoside was not 
available for investigation at the time of these 
experiments. 1:3- dithiols have not been tested as 
antidotes / 
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antidotes to poisoning with gold, but it is possible 
that gold would combine more readily with these sub- 
stances than with 1:2- dithiols, in a similar manner to 
lead (vide infra). Levey and anyth (1947) analysed 
the complexes formed between dimercaprol and gold 
sodium thiosuiphate or gold sodium thiomalate. In 
both cases, two atoms of gold were present for each 
molecule of dimercaprol, indicating an inability to 
form a cyclic compound like that postulated for the 
arsenic-dimercaprol complex. 
Levey and . mybh also found that the admini- 
stration of dimercaprol increased the survival -time 
of rats injected subcutaneously with 75mg. of gold /kg. 
as gold sodium thiosulphate, but some of the animals 
died of renal damage later. This is reminiscent of 
the effect of dimercaprol in cadmium poisoning 
(Gilman et al. 1946b; Tepperman, 1947). However, 
no direction of gold by dimercaprol towards the 
kidneys could be found in the present experiments, 
possibly because of the different species, dosages, 
and route of administration used. 
Lead/ 
94. 
Lead: Acute distributions. 
In contrast to the cases of gold and mercury, 
the fate of lead in the body has been the subject of 
extensive investigations. Since comparatively large 
amounts of lead can be administered to animals with- 
out causing early death, and adequately sensitive 
chemical methods have been available for some years, 
a number of satisfactory studies have been carried 
out. The radio -active isotopes of lead have been 
used previously (Lomholt, 1924; Behrens, 1925; 
Ginsburg and Weatherall, 1948; etc.) for tracing the 
metabolism of lead by similar methods to that used in 
the present studies, and by means of autoradiographs. 
Because of the abundance of data which has 
accrued from these works, only those results immedi- 
ately applicable to the present discussion will be 
considered; that is, those in which rabbits were 
poisoned by the intravenous administration of lead 
salts. 
Forty -five minutes after the injection of 30 or 
70.7mg. of lead /kg. as lead nitrate, about 25% of the 
dose/ 
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dose was found in the blood, 35% in skeletal muscle, 
5% in the liver, and 5% in the bones (;chtit z and 
Bernhardt, 1925). At one hour and six hours after 
the administration of 2mg. of lead /kg. as the acetate, 
Ginsburg and Weatherall (1948) found 50% of the dose 
in the liver, and high concentrations of lead in the 
spleen, bone marrow, kidneys, lungs, and bone. 
Weyrauch (1931) obtained similar results sixteen 
hours after administering 12mg. of lead /kg. as the 
nitrate. By twenty -four hours, little further change 
occurred, and about 1% of the dose had been excreted 
in the urine (Ginsburg and Weatherall). 
has been stated already, the results obtained 
in the present series of experiments were consistent 
with those reported by Ginsburg and Weatherall in the 
case of the 0.01Tn1M4. /kg. dose of lead, and by Weather - 
all for the 0.1mM /kg. dose. 
Treatment with dimercaprol glucoside greatly 
increased the urinary and biliary excretion of lead. 
These effects also occurred after the administration 
of dimercaprol (Ginsburg and Weatherall, 1948, 1949), 
but in that case were of smaller magnitude. After 
raising/ 
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raising the dose of lead acetate to 0.1mM. /kg. and 
retaining the same treatment with dimercaprol or 
dimercaprol glucoside, the proportion of the dose 
excreted in the urine was diminished, though the 
actual weight of lead excreted was increased. It is 
interesting that, under these conditions, dimercaprol 
and dimercaprol glucoside were approximately equally 1 
effective in increasing the urinary excretion of lead. 
Possibly this decreased efficiency of the glucoside 
in comparison to dimercaprol after a large dose of 
lead can be explained by a greater proportion of the 
dose of lead occurring in intracellular sites, to 
which the glucoside is unable to penetrate. However, 
in contrast to the results obtained with mercury, 
the lead content of the plasma was not observed to 
increase after administration of dimercaprol gluco- 
side; and no other evidence of an extracellular dis- 
tribution was obtained. 
In spite of the reports by some authors (Braun 
et al. 1946; Germuth and Eagle, 1948) of a potenti- 
ating action of dimercaprol in acute lead poisoning, 
no direction of lead by dimercaprol to some suscept- 
ible organ has been observed. The investigations on 
the/ 
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the effect of dimercaprol on the mortality -rates of 
animals poisoned with lead have been mentioned briefly 
in the Introduction. It seems likely that in those 
cases in which dimercaprol has potentiated the action 
of lead, rapid mobilization of that element from sub- 
cutaneous or intraperitoneal depots has taken place. 
Germuth and Eagle (1948) found that a preformed com- 
plex of lead and dimercaprol was of equal toxicity to 
that of lead acetate itself. This is reminiscent 
of the toxicities of the oxophenarsine - and mercury - 
dimercaprol compounds mentioned previously (p.83). 
Possibly in the case of lead also, excess dimercaprol 
has a protective action. From a study of the 
dosages of lead and dimercaprol used in these tests 
of dimercaprol as an antidote, the impression is 
gained that where the two substances are likely to 
meet in such proportions that more than one molecule 
of dimercaprol is present for each atom of lead, 
then the action of dimercaprol tends to be beneficial. 
Certainly such an action has been found in those 
cases where indicators of poisoning, other than 
death, were studied, and hence smaller doses of lead 
were/ 
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were administered (Weatherall, 1948; Chiodi and 
Samm.artino, 1948; Mack, 1948) . 
While arsenic probably forms a very stable five - 
membered ring with dimercaprol, there is no evidence 
that lead acts in a similar manner. Indeed, the 
greater size of the atom of lead, and the difference 
in valency possibly indicate that a six- membered 
ring might prove more stable. 
It was with these considerations in mind that 
experiments were carried out to test the ability of 
a 1 :3- and a 1:4- dithiol to promote the excretion of 
lead. From the limited information available, it 
appears that lead combines more readily with a 1 :3- 
dithiol than with either a 1:2- or a 1:4- dithiol; at 
any rate, the urinary excretion of lead was greatest 
after the administration of 1 :3- dimercaptopropanol, 
in spite of the small dose of this substance which 
was given. 
Subacute distributions: 
The distribution of lead in the untreated 
animal showed no unexpected features. As has gener- 
ally been found in rabbits (Kisskalt and Friedmann, 
1914; Lomholt, 1924; Kehoe and Themann, 1933) the 
excretion/ 
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excretion of lead was greater in the faeces than in 
the urine after the first day or two, and the combine 
excretion amounted to about half the total dose in 
three weeks. The rate of excretion roughly followed 
an exponential curve, and has reached a very low 
level by the end of the experiments. 
The lead remaining in the body was located mainl 
in the bones; bone marrow and liver were the only 
other tissues in which concentrations usually 
exceeded lyg. of lead per gramme. The present figures 
for the concentrations of lead in skeletal muscle and 
brain are loner than those obtained by Kisskalt and 
Friedmann (1914) and by Kehoe and Thamann (1933). 
However, the method employed by the latter authors 
was unreliable (Kehoe et al. 1935), and their figures 
may be disregarded. 
The effects of treatment were mall. The admin- 
istration of dimercaprol possibly induced a slight 
increase in the urinary excretion of lead. Germuth 
and Eagle (1948) observed larger increments in the 
urinary excretion of lead by rabbits up to eleven 
days after the last dose of lead, but they had 
administered/ 
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administered several doses of 200mg. of lead acetate 
subcutaneously and their rabbits therefore had a depot 
from which lead was almost certainly being continuous- 
ly absorbed and was in addition possibly mobilized by 
dimercaprol. Even so, as here, successive doses of 
dimercaprol had a rapidly diminishing effect on urin- 
ary excretion, and any effect on faecal excretion was 
obscured by a diminished output of faeces. The amoun 
of lead in blood cells decreased during treatment, and 
probably accounted for a large part of all the extra 
lead excreted. As stated previously, the bones may 
also have contributed a little. A decreased concen- 
tration of lead in the bones of rabbits poisoned with 
large amounts of lead and treated with dimercaprol has 
been reported by Braun et al. (1949), but treatment 
was initiated at an early stage of pòisoning. The 
data of Ryder et al. (1947) and of Telf er (1947) 
suggest that dimercaprol has rather more effect on the 
lead of the blood cells, and urine in man than in 
rabbits. Ryder et al. (1947) also state that extend- 
ed courses of treatment with dimercaprol were prohib- 
ited by the occurrence of toxic effects due to the 
dithiol/ 
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dithiol. It seems possible that the use of dimercap- 
rol glucoside might overcome this difficulty. 
The changes after parathyroid extract were also 
minimal. There was no increase in the excretion of 
lead in the blood cells. It does not appear that, 
with the doses used in the rabbit, parathyroid 
extract has any appreciable effect on the distribution 
of lead once most of the lead is deposited in the 
bones. Consequently, the expectations based on the 
use of dimercaprol and parathyroid extract together 
were not fulfilled, and the negative results of the 
(combination must be attributed to the lack of action 




Few generalizations on the actions of di- 
thiols can be made from these studies. The one con- 
sistent finding is that the urinary excretion of the 
poison was increased in each case by treatment with 
dithiols, while the faecal excretion was not signifi- 
cantly altered. The increased urinary excretion has 
been found in various studies of the effect of dimer- 
caprol in metallic poisoning - by arsenic (Chance and 
Levey, 1947), by zinc (Bruner, 1950), and by cadmium 
(Tepperman, 1947), though in the latter case the 
faecal excretion was also enhanced. It has also 
been reported that dimercaprol glucoside increases 
the urinary excretion of copper and zinc in normal 
subjects (McCance and Widdowson, 1946) . It appears, 
therefore, that the antidotal action of the dithiols 
consists not only of an inactivation of the poison 
but also of an increased elimination of the substance 
from the body. 
There was no consistent effect by dithiols on 
the tissue distributions of the elements investigated 
in the present work. For instance, dimercaprol 
greatly/ 
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greatly reduced the concentration of mercury in the 
kidneys, but did not affect the concentrations of 
gold or lead in that site although those concen- 
trations were quite high; and Tepperman (1947) has 
reported that the amounts of cadmium in the kidneys 
of animals poisoned with this metal are increased 
by treatment with dimercaprol. Dimercaprol gluco- 
side increased the concentration of mercury, but not 
of lead, in the plasma, while dimercaprol had no 
effect on the concentrations of either element in 
the plasma. It appears that at present, the actions 
of dithiols on the tissue distributions of any metal 
cannot be predicted from their actions on the distri- 
bution of another metal; the effect of each dithiol 
on each element must receive individual investigation. 
The different tissue distributions shown by 
metallic substances is indicative in itself of the 
varying affinities of these substances for certain 
chemical configurations. Mercury does not concen- 
trate in the spleens of rabbits, and is readily 
removed from the body by treatment with dimercaprol; 
gold and lead occur in high concentrations in the 
spleens of these animals and are not readily removed 
f rom/ 
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from there, o:r indeed from the rest of the body, by 
dimercaprol. Possibly, therefore, a knowledge of 
the constituent of the splenic cells with which gold 
and lead combine might indicate another type of com- 
pound possessing greater affinity for these elements 
than does dimercaprol, and hence possessing greater 
antidotal activity. An alternative, and more empiri- 
cal, approach to the problem is the testing of other 
dithiols and compounds known to combine with gold and 
lead in vitro. As has been shown, 1 :3- dimercapto- 
propanol has given promising results in poisoning with 
lead. The essential point appears to be that recog- 
nition of the chemical affinities of metallic poisons 





Studies have been made of the distribution 
and excretion of mercury, gold and lead, in 
rabbits, without and with treatment with dithiols 
The method involves the use of radio- active iso- 
topes of these elements. 
2. Mercury. 
After the intravenous injection of 5i.M. /kg. 
of mercuric chloride, the highest concentrations 
of mercury were found in the kidneys. Of the 
other tissues, only the liver contained more than 
one microgramme of mercury per gramme consistent- 
ly. The excretion of mercury was slow and 
accounted for only two -thirds of the dose after 
two weeks, occurring mainly in the urine. 
After treatment with dimercaprol, much 
smaller amounts of mercury were found in the 
kidneys. The excretion of mercury in the urine 
was greatly enhanced, but the faecal excretion 
was unaffected. These changes were found even 
when/ 
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when treatment was delayed until nine days after 
poisoning. 
Similar changes occurred after the admini- 
stration of dimercaprol glucoside, except that 
the concentrations of mercury in the plasma, and 
the biliary excretion, increased. The urinary 
excretion of mercury was less than that obtained 
after treatment with dimercaprol. 
3. Gold. 
After the intravenous injection of 0.01mó./ 
kg. of gold chloride, high concentrations of gold 
were found in the spleen, kidneys, plasma, bone 
marrow, liver and bile. Excretion occurred very 
slowly, about one -fifth of the dose being elimi- 
nated in the urine and faeces in five days. 
After treatment with dimercaprol, the concen 
trations of gold in the blood were reduced and 
the urinary and biliary excretion increased. No 
substantial change occurred in the amounts of 
gold found in other tissues, or in the faecal 
excretion. 
4. Lead. 
High concentrations of lead were found in 
the/ 
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the liver, spleen, bone marrow, epiphyses, and 
kidneys, twenty -four hours after the intravenous 
injection of 0.OJ.niM. /kg. of lead acetate. Only 
1 -4 per cent of the dose was excreted in the 
urine in this period. 
After the administration of dimercaprol 
glucoside, the quantities of lead in the liver 
and blood cells decreased. This was accompanied 
by increased urinary and biliary excretion of 
lead. 
5. Both dimercaprol and dimercaprol glucoside 
increased the urinary excretion of lead after the 
injection of O.1mM. /kg. of lead acetate, and were 
approximately equally effective. 
6. After the intravenous injection of O.OLii. /k 
of lead acetate, treatment with 1 :4- dithioery- 
thritol slightly, and with 1:3- dimercaptopropanol 
greatly, increased the urinary excretion of lead. 
7. Twenty -one days after the intravenous injec- 
tion of 0.01M./kg. of lead acetate, about 50 per 
cent of the dose had been excreted, predominanti' 
in/ 
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in the faeces, and the bones contained about 
25 per cent of the dose. The bone marrow and 
the liver were the only other tissues which con- 
sistently contained more than 1 per cent. 
Treatment with dimercaprol or parathyroid 
extract or both, caused no substantial change in - 
the distribution or the excretion of lead, apart 
from a transient increase in the urinary excretion 
after dimercaprol. 
8 The method and the significance of these 
results are discussed. 
109. 
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